Found 2669 matching trials
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) PHASE2 The purpose of this study is to examine how effective rituximab or tocilizu...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas PHASE1 This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma PHASE4 The purpose of this study is to determine whether the rituximab administrat...
Show More Location
Hospital Infanta Cristina
Learn More & Join Trial
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers PHASE1 This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Show More Location
University of Arizona Cancer Center - North Campus /ID# 16721
Learn More & Join Trial
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction N/A Study Aim is creation of the Hospital Register of patients with heart failu...
Show More Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Learn More & Join Trial
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma PHASE3 This study will assess the efficacy and safety of mosunetuzumab in combinat...
Show More Status
Active Not Recruiting
Location
City of Hope Cancer Center
Learn More & Join Trial
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma PHASE2 Everolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) PHASE3 The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy PHASE4 That anti-TNF therapy and rituximab therapy are equally effective in treati...
Show More Learn More & Join Trial